Literature DB >> 17690207

Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube.

Mogens Kruhøffer1, Lars Dyrskjøt, Thorsten Voss, Raija L P Lindberg, Ralf Wyrich, Thomas Thykjaer, Torben F Orntoft.   

Abstract

We have developed a procedure for isolation of microRNA and genomic DNA in addition to total RNA from whole blood stabilized in PAXgene Blood RNA tubes. The procedure is based on automatic extraction on a BioRobot MDx and includes isolation of DNA from a fraction of the stabilized blood and recovery of small RNA species that are otherwise lost. The procedure presented here is suitable for large-scale experiments and is amenable to further automation. Procured total RNA and DNA was tested using Affymetrix Expression and single-nucleotide polymorphism GeneChips, respectively, and isolated microRNA was tested using spotted locked nucleic acid-based microarrays. We conclude that the yield and quality of total RNA, microRNA, and DNA from a single PAXgene blood RNA tube is sufficient for downstream microarray analysis.

Mesh:

Substances:

Year:  2007        PMID: 17690207      PMCID: PMC1975097          DOI: 10.2353/jmoldx.2007.060175

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  30 in total

1.  Analysis of spontaneous mRNA cytokine production in peripheral blood.

Authors:  Patrick Stordeur; Ling Zhou; Michel Goldman
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

2.  Stabilization of mRNA expression in whole blood samples.

Authors:  Lynne Rainen; Uwe Oelmueller; Stewart Jurgensen; Ralf Wyrich; Cynthia Ballas; Jim Schram; Chris Herdman; Danute Bankaitis-Davis; Nancy Nicholls; David Trollinger; Victor Tryon
Journal:  Clin Chem       Date:  2002-11       Impact factor: 8.327

3.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

Authors:  Y Murakami; T Yasuda; K Saigo; T Urashima; H Toyoda; T Okanoue; K Shimotohno
Journal:  Oncogene       Date:  2006-04-20       Impact factor: 9.867

Review 4.  Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.

Authors:  Raija L P Lindberg; Ludwig Kappos
Journal:  Expert Rev Mol Diagn       Date:  2006-11       Impact factor: 5.225

5.  Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.

Authors:  F K Tan; X Zhou; M D Mayes; P Gourh; X Guo; C Marcum; L Jin; F C Arnett
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

6.  CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.

Authors:  Robert W Georgantas; Richard Hildreth; Sebastien Morisot; Jonathan Alder; Chang-gong Liu; Shelly Heimfeld; George A Calin; Carlo M Croce; Curt I Civin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

7.  Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics.

Authors:  Jong Sook Park; Hun Soo Chang; Choon-Sik Park; June-Hyuk Lee; Yong Mok Lee; Jung Hee Choi; Hae-Sim Park; Lyoung Hyo Kim; Byung Lae Park; Yoo Hyun Choi; Hyoung Doo Shin
Journal:  Pharmacogenet Genomics       Date:  2005-07       Impact factor: 2.089

8.  Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.

Authors:  M C Müller; K Merx; A Weisser; S Kreil; T Lahaye; R Hehlmann; A Hochhaus
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528

Review 9.  Small RNAs and non-small cell lung cancer.

Authors:  Alex W Tong
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

Review 10.  MicroRNAs and the hallmarks of cancer.

Authors:  T Dalmay; D R Edwards
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

View more
  16 in total

1.  Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Authors:  S B Krintel; C Dehlendorff; M L Hetland; K Hørslev-Petersen; K K Andersen; P Junker; J Pødenphant; T Ellingsen; P Ahlquist; H M Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; H C Horn; A Jørgensen; J Raun; C G Ammitzbøll; M Østergaard; K Stengaard-Pedersen; J S Johansen
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

2.  Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approaches.

Authors:  Andrea Gaarz; Svenja Debey-Pascher; Sabine Classen; Daniela Eggle; Birgit Gathof; Jing Chen; Jian-Bing Fan; Thorsten Voss; Joachim L Schultze; Andrea Staratschek-Jox
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

3.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

4.  Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.

Authors:  V B Kraus; B Burnett; J Coindreau; S Cottrell; D Eyre; M Gendreau; J Gardiner; P Garnero; J Hardin; Y Henrotin; D Heinegård; A Ko; L S Lohmander; G Matthews; J Menetski; R Moskowitz; S Persiani; A R Poole; J-C Rousseau; M Todman
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

5.  Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.

Authors:  Daniel Gilbert Weber; Swaantje Casjens; Peter Rozynek; Martin Lehnert; Sandra Zilch-Schöneweis; Oleksandr Bryk; Dirk Taeger; Maria Gomolka; Michaela Kreuzer; Heinz Otten; Beate Pesch; Georg Johnen; Thomas Brüning
Journal:  Biomark Insights       Date:  2010-09-22

Review 6.  Cellular defense system gene expression profiling of human whole blood: opportunities to predict health benefits in response to diet.

Authors:  Janice E Drew
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

7.  Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?

Authors:  Sofie Haglund; Sven Almer; Curt Peterson; Jan Söderman
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

8.  Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects.

Authors:  Fernando M Pimentel-Santos; Dário Ligeiro; Mafalda Matos; Ana F Mourão; José Costa; Helena Santos; Anabela Barcelos; Fátima Godinho; Patricia Pinto; Margarida Cruz; João E Fonseca; Henrique Guedes-Pinto; Jaime C Branco; Matthew A Brown; Gethin P Thomas
Journal:  Arthritis Res Ther       Date:  2011-04-07       Impact factor: 5.156

9.  Stress-related alcohol consumption in heavy drinkers correlates with expression of miR-10a, miR-21, and components of the TAR-RNA-binding protein-associated complex.

Authors:  Robert D Beech; Janine J Leffert; Aiping Lin; Kwangik A Hong; Julie Hansen; Sheila Umlauf; Shrikant Mane; Hongyu Zhao; Rajita Sinha
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.928

10.  Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects.

Authors:  Ole Lagatie; Tom Van Loy; Luc Tritsmans; Lieven J Stuyver
Journal:  Virol J       Date:  2014-03-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.